vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Eightco Holdings Inc. (ORBS). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $10.2M, roughly 1.9× Eightco Holdings Inc.). Apyx Medical Corp runs the higher net margin — -6.8% vs -2281.6%, a 2274.8% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -49.9%). Apyx Medical Corp produced more free cash flow last quarter ($-2.8M vs $-11.0M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 13.1%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
APYX vs ORBS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $10.2M |
| Net Profit | $-1.3M | $-232.5M |
| Gross Margin | 62.6% | -13.0% |
| Operating Margin | 0.1% | -475.0% |
| Net Margin | -6.8% | -2281.6% |
| Revenue YoY | 34.7% | -49.9% |
| Net Profit YoY | 71.9% | -9183.3% |
| EPS (diluted) | — | $-2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $10.2M | ||
| Q3 25 | $12.9M | $5.3M | ||
| Q2 25 | $11.4M | $7.6M | ||
| Q1 25 | $9.4M | $9.9M | ||
| Q4 24 | $14.2M | $20.3M | ||
| Q3 24 | $11.5M | $6.1M | ||
| Q2 24 | $12.1M | $5.3M | ||
| Q1 24 | $10.2M | $8.0M |
| Q4 25 | $-1.3M | $-232.5M | ||
| Q3 25 | $-2.0M | $-25.8M | ||
| Q2 25 | $-3.8M | $-1.2M | ||
| Q1 25 | $-4.2M | $-2.5M | ||
| Q4 24 | $-4.6M | $-2.5M | ||
| Q3 24 | $-4.7M | $-3.2M | ||
| Q2 24 | $-6.6M | $4.4M | ||
| Q1 24 | $-7.6M | $1.9M |
| Q4 25 | 62.6% | -13.0% | ||
| Q3 25 | 64.4% | -3.7% | ||
| Q2 25 | 62.3% | 16.4% | ||
| Q1 25 | 60.1% | 8.2% | ||
| Q4 24 | 63.0% | 8.2% | ||
| Q3 24 | 60.5% | 26.5% | ||
| Q2 24 | 61.7% | 25.1% | ||
| Q1 24 | 58.1% | 17.5% |
| Q4 25 | 0.1% | -475.0% | ||
| Q3 25 | -6.5% | -116.9% | ||
| Q2 25 | -22.6% | -15.9% | ||
| Q1 25 | -32.4% | -14.3% | ||
| Q4 24 | -21.4% | -11.9% | ||
| Q3 24 | -31.6% | -29.1% | ||
| Q2 24 | -45.7% | -16.4% | ||
| Q1 24 | -64.6% | -39.6% |
| Q4 25 | -6.8% | -2281.6% | ||
| Q3 25 | -15.4% | -487.6% | ||
| Q2 25 | -33.2% | -15.4% | ||
| Q1 25 | -44.0% | -25.7% | ||
| Q4 24 | -32.5% | -12.3% | ||
| Q3 24 | -40.9% | -52.5% | ||
| Q2 24 | -54.0% | 84.2% | ||
| Q1 24 | -74.0% | 24.4% |
| Q4 25 | — | $-2.34 | ||
| Q3 25 | — | $-0.58 | ||
| Q2 25 | — | $-0.38 | ||
| Q1 25 | — | $-0.84 | ||
| Q4 24 | — | $-1.44 | ||
| Q3 24 | — | $-1.77 | ||
| Q2 24 | $-0.19 | $2.15 | ||
| Q1 24 | $-0.22 | $1.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $58.5M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $232.6M |
| Total Assets | $66.8M | $250.2M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $58.5M | ||
| Q3 25 | $25.1M | $23.7M | ||
| Q2 25 | $29.3M | $696.3K | ||
| Q1 25 | $31.0M | $434.4K | ||
| Q4 24 | $31.7M | $239.2K | ||
| Q3 24 | $28.0M | $2.4M | ||
| Q2 24 | $32.7M | $363.1K | ||
| Q1 24 | $37.3M | $808.8K |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $232.6M | ||
| Q3 25 | $5.8M | $339.2M | ||
| Q2 25 | $7.3M | $8.9M | ||
| Q1 25 | $10.5M | $9.7M | ||
| Q4 24 | $14.2M | $11.9M | ||
| Q3 24 | $11.0M | $13.0M | ||
| Q2 24 | $14.7M | $13.8M | ||
| Q1 24 | $20.3M | $3.9M |
| Q4 25 | $66.8M | $250.2M | ||
| Q3 25 | $57.4M | $355.5M | ||
| Q2 25 | $58.2M | $48.7M | ||
| Q1 25 | $60.2M | $47.6M | ||
| Q4 24 | $64.8M | $50.8M | ||
| Q3 24 | $60.7M | $49.2M | ||
| Q2 24 | $65.4M | $48.4M | ||
| Q1 24 | $70.7M | $50.2M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $-11.0M |
| Free Cash FlowOCF − Capex | $-2.8M | $-11.0M |
| FCF MarginFCF / Revenue | -14.6% | -107.7% |
| Capex IntensityCapex / Revenue | 1.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $-11.0M | ||
| Q3 25 | $-3.5M | $-1.6M | ||
| Q2 25 | $-1.2M | $-659.2K | ||
| Q1 25 | $-702.0K | $999.8K | ||
| Q4 24 | $-2.9M | $-6.6M | ||
| Q3 24 | $-4.4M | $77.7K | ||
| Q2 24 | $-4.3M | $-440.3K | ||
| Q1 24 | $-6.3M | $-723.3K |
| Q4 25 | $-2.8M | $-11.0M | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | $-661.3K | ||
| Q1 25 | $-757.0K | $999.7K | ||
| Q4 24 | $-3.2M | $-6.6M | ||
| Q3 24 | $-4.6M | $73.0K | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
| Q4 25 | -14.6% | -107.7% | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | -8.7% | ||
| Q1 25 | -8.0% | 10.1% | ||
| Q4 24 | -22.4% | -32.7% | ||
| Q3 24 | -40.0% | 1.2% | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
| Q4 25 | 1.4% | 0.0% | ||
| Q3 25 | 4.0% | 0.0% | ||
| Q2 25 | 2.3% | 0.0% | ||
| Q1 25 | 0.6% | 0.0% | ||
| Q4 24 | 1.7% | 0.0% | ||
| Q3 24 | 1.3% | 0.1% | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.10× | ||
| Q1 24 | — | -0.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
